Celebrating Our
10th Anniversary

2018 sees PrimeVigilance celebrate 10 Years of
delivering Pharmacovigilance and Medical Information
excellence to our customers around the globe.

About us

Pharmacovigilance Free Webinar

PART 2 of EVDAS-related expectations from MAHs
UPDATE on the discussions taking place during pilot phase

14 June 2018 – 15.00 GMT, 16.00 CEST, 10.00 EDT
with Dr Cvijeta Bielen, Medical Director

Register Now

Drug Safety

With a proven track record in pharmacovigilance,
we also manage medical information queries,
adverse events and product quality complaints.

About Us

Global Drug
Safety Services

PrimeVigilance was founded in 2008
with now over 500 employees with offices
in the UK, US and Europe.

About Us

Today’s Needs

Our expertise and commercial vision
means you can rely on us to deliver high quality,
compliant and cost-effective solutions

About us

    Clinical trial safety and postmarketing

    Dedicated to providing Pharmacovigilance services for over 10 years, we cover the entire product life cycle to better assists client with the effective management of their drug safety information.



    Healthcare professional and customer queries

    PrimeVigilance is a quality resource for concise, timely and accurate communication with highly trained, industry experienced healthcare professionals providing medical information.


    EVDAS outputs are available to MAHs – what now?

    EVDAS outputs

    Featured Speaker:
    Dr Cvijeta Bielen
    Medical Director

    Watch now

    What is Pharmacovigilance?

    In partnership with our clients, PrimeVigilance is committed to improving patient health.



    Join the PrimeVigilance team

    Our success begins with our people. Build your career in one of the most rewarding fields in the world.


    News – Part 2 of PrimeVigilance Webinar “EVDAS outputs are available to MAHs – what now?”


    News – Dr Jan Petracek to speak at 10th DIA China Annual Meeting May 22-25, 2018


    News -PrimeVigilance Associate Director and Head of QA Unit to Lecture at “Ordem dos Farmacêuticos” Training Program in Porto, Portugal.